SIH Partners’s Rhythm Pharmaceuticals RYTM Stock Holding History

SIH Partners’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,980	Closed	-$211K	–	284
2025 Q1	$211K	Buy	+3,980	New	+$221K	0.01%	222

Other funds holding RYTM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SIH Partners's RYTM Position: Q2 2025 in Review

SIH Partners sold out of Rhythm Pharmaceuticals (RYTM) in Q2 2025, closing a stake of 3,980 shares — an estimated $211K sold.

SIH Partners first reported a position in RYTM in Q1 2025 and held it in 1 quarter. The position peaked at $211K in Q1 2025. 227 funds tracked by Wall St. Rank hold RYTM as of Q2 2025.

SIH Partners reported no remaining Rhythm Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
SIH Partners sold 3,980 Rhythm Pharmaceuticals shares in Q2 2025, an estimated $211K.
SIH Partners first reported a position in Rhythm Pharmaceuticals in Q1 2025 and held it in 1 quarter.
SIH Partners's Rhythm Pharmaceuticals position peaked at $211K in Q1 2025.
227 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2025.

Based on SIH Partners's 13F filing for Q2 2025, filed 14 Aug 2025.